Skip to content
value.today

Pulmatrix Inc

Total raised
$38 M
3 rounds on record
Latest round
$2 M
Mar 2015
First round on record
Oct 2009
Today
Private
No later event on record

Funding rounds

3 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Pulmatrix Inc
MonthRaisedRaiseSizeInvestorsSoldFiling
Jun 2015$10 MIssued in a merger or acquisition$10 to $50 million

Pulmatrix Inc: Private sale, Jun 2015

Investors in this round

11 investors had bought by the notice of Jun 30, 2015: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $34 M offered; $24 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Hava · Executive Officer · Chief Scientific Officer
  • Robert Clarke · Executive Officer, Director · Chief Executive Officer and Member of the Board of Directors
  • David Edwards · Director
  • David Maki · Director
  • Kurt Graves · Director
  • Michael Higgins · Director
  • Robert Connelly · Director
  • Scott Rocklage · Director
  • Steven Gillis · Director
  • Terrance McGuire · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “The total offering amount includes (i) $10,000,000, representing the aggregate gross proceeds from the offering and (ii) $24,124,543, representing the total aggregate exercise price of warrants issued in the offering.”
  • On a merger: “The offering was made in connection with, and was cross-conditioned with the closing of, a merger between Pulmatrix Operating Company, Inc. and Pulmatrix, Inc.”

Signed by Michelle S. Siegert, Assistant Secretary. Source: SEC Form D, newest notice filed Jun 30, 2015. Read the notice at the SEC.

equity, optionsSEC
Mar 2015$2 MNo. 3Under $2 million

Pulmatrix Inc: Raise no. 3, Mar 2015

Investors in this round

1 investor had bought by the notice of Jun 30, 2015: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Hava · Executive Officer · Chief Scientific Officer
  • Robert Clarke · Executive Officer, Director · Chief Executive Officer and Member of the Board of Directors
  • David Edwards · Director
  • David Maki · Director
  • Kurt Graves · Director
  • Michael Higgins · Director
  • Robert Connelly · Director
  • Scott Rocklage · Director
  • Steven Gillis · Director
  • Terrance McGuire · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “The total offering amount is based on the issuance of 589,608 shares of common stock in the merger with Pulmatrix, Inc. in respect of the shares offered by Pulmatrix Operating Company, Inc. at an assumed price of $2.75 per share received in the merger.”

Signed by Michelle S. Siegert, Assistant Secretary. Source: SEC Form D, newest notice filed Jun 30, 2015. Read the notice at the SEC.

equitySEC
Aug 2011$21 MNo. 2$10 to $50 million

Pulmatrix Inc: Raise no. 2, Aug 2011

Investors in this round

11 investors had bought by the notice of Feb 22, 2013: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$21 M of $24 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them, other: Unsecured Convertible Promissory Notes and Warrants to Purchase Capital Stock
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Robert T. Clarke · Executive Officer, Director
  • David T. Edwards · Director
  • David T. Maki · Director
  • Kurt T. Graves · Director
  • Lauren T. Silverman · Director
  • Robert T. Connelly · Director
  • Scott T. Rocklage · Director
  • Steven T. Gillis · Director
  • Terry T. McGuire · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Robert Clarke, PhD, President and Chief Executive Officer. Source: SEC Form D and 2 amendments, newest notice filed Feb 22, 2013. Read the notice at the SEC.

debt, optionsSEC
Oct 2009$15 MNo. 1$10 to $50 million

Pulmatrix Inc: Raise no. 1, Oct 2009

Investors in this round

10 investors had bought by the notice of Nov 2, 2009: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$15 M of $30 M offered; $15 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Robert T Connelly · Executive Officer, Director
  • David T Edwards · Director
  • Lauren T Silverman · Director
  • Mark T Gabrielson · Director
  • Scott T Rocklage · Director
  • Steven T Gillis · Director
  • Terry T McGuire · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Sale of Series B Preferred Stock & Issuance of Series B-1 Preferred Stock.”

Signed by Robert T. Connelly, President and CEO. Source: SEC Form D, newest notice filed Nov 2, 2009. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Pulmatrix Inc chose not to state its revenue in its newest notice of a funding round (Jun 2015).

    SEC Form D · Jun 2015

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jun 2015

That is all the official record says: Pulmatrix Inc has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

In its own words

How the company describes itself to search engines on its website, word for word.

“With iSPERSE ™ technology, PULMATRiX is expanding therapeutic care for patients with serious disease through a new generation of PULMONARY-DELIVERED THERAPEUTICS.”

Source: The company's website · as of Nov 15, 2026

Products and services#

No products or services on record: its website does not describe any in structured form (a page that declares itself a product or service), and Wikidata lists none.

Investors#

No investor of Pulmatrix Inc is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 11 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Pulmatrix Inc
NameRoleNamed in
David HavaChief Scientific OfficerJun 2015
Robert ClarkeChief Executive Officer and Member of the Board of DirectorsJun 2015
Robert T. ClarkeExecutive officerFeb 2013
Robert T ClarkeExecutive officerOct 2012
Robert T ConnellyExecutive officerAug 2011
David EdwardsDirectorJun 2015
David MakiDirectorJun 2015
Kurt GravesDirectorJun 2015
Michael HigginsDirectorJun 2015
Robert ClarkeChief Executive Officer and Member of the Board of DirectorsJun 2015
Robert ConnellyDirectorJun 2015
Scott RocklageDirectorJun 2015
Steven GillisDirectorJun 2015
Terrance McGuireDirectorJun 2015
David T. EdwardsDirectorFeb 2013
David T. MakiDirectorFeb 2013
Kurt T. GravesDirectorFeb 2013
Lauren T. SilvermanDirectorFeb 2013
Robert T. ClarkeDirectorFeb 2013
Robert T. ConnellyDirectorFeb 2013
Scott T. RocklageDirectorFeb 2013
Steven T. GillisDirectorFeb 2013
Terry T. McGuireDirectorFeb 2013
David T EdwardsDirectorOct 2012
David T MakiDirectorOct 2012
Kurt T GravesDirectorOct 2012
Lauren T SilvermanDirectorOct 2012
Robert T ClarkeDirectorOct 2012
Robert T ConnellyDirectorOct 2012
Scott T RocklageDirectorOct 2012
Steven T GillisDirectorOct 2012
Terry T McGuireDirectorOct 2012
Mark T GabrielsonDirectorNov 2009

About

Company in Lexington, United States.